Peter Martin   Professor of Medicine

Phone
  • +1 646 962 2064

Dr. Peter Martin is a Professor of Medicine in the Division of Hematology/Oncology at Weill Cornell Medical College. A graduate of University of Alberta Medical School, Dr. Martin completed his residency in internal medicine and fellowship in hematology at McGill University. Prior to joining the faculty at Weill Cornell Medical College, he completed a Master's Degree in Clinical Investigation and Translational Research at the Weill Cornell School of Graduate Sciences.

Dr. Martin specializes in caring for patients with lymphoma. His research focuses on the clinical investigation of new and promising therapies, and he passionately believes that clinical trials are the gateway to a better future. He is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the Alliance for Clinical Trials in Oncology. He is board certified in Hematology.

Publications

Sort by

selected publications

Research

Sort by

Funding awarded

  • Characteristics and Outcomes of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Receiving Frontline Treatment at Cancer Centers Within the LEO Cohort  awarded by Genentech, Inc. Principal Investigator 2023 - 2025
  • missing activity Co-Investigator 2021 - 2026
  • Mechanism-Based Targeting of Mantle Cell Lymphoma  awarded by National Cancer Institute Co-Investigator 2018 - 2025
  • missing activity Co-Investigator 2022 - 2024
  • missing activity Co-Principal Investigator 2018 - 2023
  • Inhibiting EZH2 to Improve Immunotherapies in B-Cell Lymphomas  awarded by Lymphoma Research Foundation Key Personnel 2024 - 2027
  • The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study  awarded by Genentech, Inc. Principal Investigator Subaward 2021 - 2026
  • Characteristics and Outcomes of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Receiving Frontline Treatment at Cancer Centers Within the LEO Cohort  awarded by Genentech, Inc. Principal Investigator Subaward 2023 - 2025
  • missing activity Principal Investigator Subaward 2023 - 2024
  • missing activity Principal Investigator Subaward 2022 - 2024

Background

Contact

full name

  • Peter Martin

External Relationships

externalRelationships

  • Relationships and collaborations with for-profit and not-for-profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

    Consultant refers to an individual who provides expert advice to a business or entity (e.g., consulting on medical devices or pharmaceuticals)Consultant:
    AbbVie Inc.; AstraZeneca AB; Genentech, Inc.; Janssen Pharmaceutical Company; Merck
    Professional Services refers to a service requiring specialized knowledge and skill usually requiring a license, certification, or registration (e.g., expert witness, commissioned writing)Professional Services:
    BeiGene USA